Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Laboratories (CLB) EBIT (2022 - 2025)

Core Laboratories (CLB) has 4 years of EBIT data on record, last reported at $20.9 million in Q3 2025.

  • For Q3 2025, EBIT rose 5.68% year-over-year to $20.9 million; the TTM value through Sep 2025 reached $5.8 million, down 90.15%, while the annual FY2024 figure was $9.6 million, 82.52% down from the prior year.
  • EBIT reached $20.9 million in Q3 2025 per CLB's latest filing, up from $15.3 million in the prior quarter.
  • Across five years, EBIT topped out at $20.9 million in Q3 2025 and bottomed at -$34.8 million in Q4 2024.
  • Average EBIT over 4 years is $10.4 million, with a median of $14.7 million recorded in 2023.
  • The widest YoY moves for EBIT: up 34.97% in 2024, down 338.87% in 2024.
  • A 4-year view of EBIT shows it stood at $15.6 million in 2022, then decreased by 6.64% to $14.6 million in 2023, then plummeted by 338.87% to -$34.8 million in 2024, then soared by 160.09% to $20.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were $20.9 million in Q3 2025, $15.3 million in Q2 2025, and $4.4 million in Q1 2025.